Innovating Works

CELL THERAPY CATAPULT LIMITED

Desconocido
SMARTER: Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies a... CELL THERAPY CATAPULT LIMITED participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 Autologous immunotherapies have revolutionised cancer treatment providing impressive survival benefits in patients with blood cancers. The n...
2022-06-27 - 2025-08-31 | Financiado
EuroGCT: European consortium for communicating gene and cell based therapy information. CELL THERAPY CATAPULT LIMITED participó en un H2020: H2020-SC1-BHC-2018-2020 The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) unites 49 partner organisations and institutions acros...
2021-01-25 - 2026-01-31 | Financiado
RESTORE: RESTORE Health by Advanced Therapies Advanced Therapy Medicinal Products and Biologized Medical Dev... CELL THERAPY CATAPULT LIMITED participó en un H2020: H2020-FETFLAG-2018-2020 Recently, a new class of living drugs has been developed – Advanced Therapies which aim to transform the current focus of treatment of disea...
2019-02-08 - 2020-07-31 | Financiado
RESHAPE: Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next Generation regulatory T ce... CELL THERAPY CATAPULT LIMITED participó en un H2020: H2020-SC1-BHC-2018-2020 Adoptive transfer of regulatory T cells (Treg) is a promising new therapeutic option to reshape undesired intra-tissue immune imbalance in i...
2018-11-21 - 2024-12-31 | Financiado
AUTOSTEM: Development of closed scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturin... CELL THERAPY CATAPULT LIMITED participó en un H2020: H2020-PHC-2014-2015 AUTOSTEM will develop closed, scaleable and automated systems for therapeutic cell manufacture. The project vision is a donor-to-patient sy...
2015-12-02 - 2018-12-31 | Financiado
TETRA: Autologous Stem Cell Seeded Tissue Engineered Trachea CELL THERAPY CATAPULT LIMITED participó en un H2020: H2020-PHC-2014-2015 CLINICAL PROBLEM AND UNMET NEED There are 11,827 patients with severe structural airway disease in Europe. Even with the current standard of...
2015-09-21 - 2019-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.